Center for Substance Abuse Treatment. (2000). Changing the conversation: Improving substance abuse treatment—The National Treatment Plan Initiative. Rockville, MD: U.S. Department of Health and Human Services.
Cerny, E.H., Levy, R., Mauel, J., Mpandi, M., Mutter, M., Henzelin-Nkubana, C., Patiny, L., Tuchscherer, G., and Cerny, T. (2002). Preclinical development of a vaccine against smoking. Onkologie, 2, 406-411.
Chaloupka, F., and Pacula, R. (2000). Economics and antihealth behavior: The economic analysis of substance use and misuse. In W. Bickel and R. Vuchinich (Eds.), Reframing health behavior change with behavioural economics (pp. 89-111). Mahwah, NJ: Lawrence Erlbaum.
Coffey, R.M., Mark, T., King, E., Harwood, H., McKusick, D., Genuardi, J., Dilonardo, J., and Chalk, M. (2001). National estimates of expenditures for substance abuse treatment, 1997 (DHHS Publication No. SMA-01-3511). Rockville, MD: Center for Substance Abuse Treatment.
Cohen, P.H. (2002). Untreated addiction imposes an ethical bar to recruiting addicts for nontherapeutic studies of addictive drugs. Journal of Law, Medicine and Ethics, 30(1), 73-81.
D’Aunno, T., and Pollack, H.A. (2002). Changes in methadone treatment practices: Results from a national panel study, 1988-2000. Journal of the American Medical Association, 288(7), 850-856.
D’Aunno, T., Vaughn, M., and McElroy, P. (1999). An institutional analysis of HIV prevention efforts by the nation’s outpatient drug abuse treatment units. Journal of Health and Social Behavior, 40, 175-192.
Demain, A.L. (2000). Small bugs, big business. The economic power of the microbe. Biotechnology Advances, 18(6), 499-514.
DeRenzo, E.G. (1994). The ethics of involving psychiatrically impaired persons in research. IRB: A Review of Human Subjects Research, 16(6), 7-9.
Devi, C.M., Bai, M.V., Lal, A.V., Umashankar, P.R., and Krishnan, L.K. (2002). An improved method for isolation of anti-viper venom antibodies from chicken egg yolk. Journal of Biochemical and Biophysical Methods, 51(2), 129-138.
Dresser, R. (1996). Mentally disabled research subjects: The enduring policy issues. Journal of the American Medical Association, 276(1), 67-72.
Ernst, E. (1999). Second thoughts about safety of St. John’s wort [published erratum in Lancet, 355, 580]. Lancet, 354(9195), 2014-2016.
Farrelly, M.C., Bray, J.W., Zarkin, G.A., Wendling, B.W., and Liccardo Pacula, R. (1999). The effects of prices and policies on the demand for marijuana: Evidence from the National Household Surveys on Drug Abuse . (Working Paper No. w6940). Cambridge, MA: National Bureau of Economic Research.
Ferguson, L., Ries, R., and Russo, J. (2003). Barriers to identification and treatment of hazardous drinkers as assessed by urban/rural primary care doctors. Journal of Addictive Diseases, 22(2), 79-90.
Flannery, D.J., Williams, L.L., and Vazsonyi, A.T. (1999). Who are they with and what are they doing? Delinquent behavior, substance use, and early adolescents’ after-school time. American Journal of Orthopsychiatry, 69(2), 247-253.
Fox, B.S., Kantak, K.M., Edwards, M.A., Black, K.M., Bollinger, B.K., Botka, A.J., French, T.L., Thompson, T.L., Schad, V.C., Greenstein, J.L., Gefter, M.L., Exley, M.A., Swain, P.A., and Briner, T.J. (1996). Efficacy of a therapeutic cocaine vaccine in rodent models. Nature Medicine, 2(10), 1129-1132.
Friedmann, P.D., Alexander, J.A., and D’Aunno, T.A. (1999). Organizational correlates of access to primary care and mental health services in drug abuse treatment units. Journal of Substance Abuse Treatment, 16(1), 71-80.